Masimo Corporation (NASDAQ:MASI) Given Consensus Recommendation of "Buy" by Analysts

Key Points

• Masimo Corporation's shares receive a consensus recommendation of "Buy" from seven analysts, with an average one-year target price of $193.60.
• Insider transactions include Director William R. Jellison purchasing 3,000 shares at an average price of $145.98, increasing his ownership by 167.60%.
• The company reported $1.33 EPS for the last quarter, exceeding estimates, with a revenue of $370.90 million, up 7.7% from the previous year.

Shares of Masimo Corporation (NASDAQ:MASI - Get Free Report) have received a consensus recommendation of "Buy" from the seven analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $193.60.

Several equities analysts have recently commented on MASI shares. BTIG Research reissued a "buy" rating on shares of Masimo in a report on Thursday, August 14th. Wall Street Zen downgraded shares of Masimo from a "buy" rating to a "hold" rating in a report on Friday, May 30th. Piper Sandler boosted their target price on shares of Masimo from $200.00 to $210.00 and gave the stock an "overweight" rating in a report on Wednesday, August 6th. Finally, Zacks Research raised shares of Masimo from a "hold" rating to a "strong-buy" rating in a report on Wednesday, September 3rd.

Insider Transactions at Masimo

In other Masimo news, Director William R. Jellison purchased 3,000 shares of the firm's stock in a transaction that occurred on Monday, August 11th. The shares were bought at an average price of $145.98 per share, with a total value of $437,940.00. Following the completion of the purchase, the director directly owned 4,790 shares in the company, valued at $699,244.20. This trade represents a 167.60% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 16.90% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Masimo

A number of hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider's stock valued at $1,894,000 after purchasing an additional 66 shares in the last quarter. Assetmark Inc. lifted its stake in Masimo by 5.0% in the second quarter. Assetmark Inc. now owns 1,539 shares of the medical equipment provider's stock worth $259,000 after purchasing an additional 73 shares during the last quarter. Xponance Inc. raised its holdings in shares of Masimo by 1.1% in the first quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider's stock worth $1,183,000 after buying an additional 76 shares during the period. Deutsche Bank AG lifted its stake in shares of Masimo by 1.5% during the 1st quarter. Deutsche Bank AG now owns 6,309 shares of the medical equipment provider's stock worth $1,051,000 after acquiring an additional 92 shares during the last quarter. Finally, State of Michigan Retirement System lifted its stake in shares of Masimo by 1.0% during the 1st quarter. State of Michigan Retirement System now owns 10,596 shares of the medical equipment provider's stock worth $1,765,000 after acquiring an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company's stock.

Masimo Price Performance

MASI stock opened at $147.19 on Monday. Masimo has a one year low of $107.98 and a one year high of $194.88. The company's fifty day moving average price is $154.41 and its 200-day moving average price is $160.14. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14. The company has a market capitalization of $8.00 billion, a PE ratio of -17.28 and a beta of 1.23.

Masimo (NASDAQ:MASI - Get Free Report) last released its earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, topping the consensus estimate of $1.22 by $0.11. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The firm had revenue of $370.90 million for the quarter, compared to the consensus estimate of $368.65 million. During the same quarter in the previous year, the firm earned $0.86 earnings per share. The company's quarterly revenue was up 7.7% compared to the same quarter last year. On average, equities analysts anticipate that Masimo will post 4.1 EPS for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.